Cramer, D. W., Fichorova, R. N., Terry, K. L., Yamamoto, H., Vitonis, A. F., Ardanaz, E., . . . Kaaks, R. (2018). Anti-CA15.3 and anti-CA125 antibodies and ovarian cancer risk: Results from the EPIC cohort. Cancer Epidemiol Biomarkers Prev.
Chicago Style citaatCramer, Daniel W., et al. "Anti-CA15.3 and Anti-CA125 Antibodies and Ovarian Cancer Risk: Results From the EPIC Cohort." Cancer Epidemiol Biomarkers Prev 2018.
MLA citatieCramer, Daniel W., et al. "Anti-CA15.3 and Anti-CA125 Antibodies and Ovarian Cancer Risk: Results From the EPIC Cohort." Cancer Epidemiol Biomarkers Prev 2018.
Let op: Deze citaties zijn niet altijd 100% accuraat.